Novel bis-cyclic guanidines as potent membrane-active antibacterial agents with therapeutic potential

Chem Commun (Camb). 2017 Oct 31;53(87):11948-11951. doi: 10.1039/c7cc07285f.

Abstract

We designed a class of small dimeric cyclic guanidine derivatives which display potent antibacterial activity against both multidrug-resistant Gram-negative and Gram-positive bacteria. They could compromise bacterial membranes without developing resistance, inhibit biofilms formed by E. coli, and exhibit excellent in vivo activity in the MRSA-infected thigh burden mouse model.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / chemistry*
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use
  • Cyclization
  • Dimerization
  • Escherichia coli / drug effects*
  • Escherichia coli Infections / drug therapy
  • Guanidine / analogs & derivatives*
  • Guanidine / pharmacology*
  • Guanidine / therapeutic use
  • Humans
  • Methicillin-Resistant Staphylococcus aureus / drug effects*
  • Mice
  • Microbial Sensitivity Tests
  • Staphylococcal Infections / drug therapy

Substances

  • Anti-Bacterial Agents
  • Guanidine